Carlsmed Inc.
CARL | NASDAQ
$14.93
-$0.84 (-5.33%)
At close: Oct 30, 2026, 3:59 PM ET
$15.00
+$0.07 (+0.47%)
After-hours:
Oct 30, 2026, 7:30 PM ET
-5.33%
(1D)No price chart data available for 1D timeframe.
Rating
45.8
+11.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #374/1028 (Top 36%)
Key Statistics
Market Data
Market Cap $407.63M
1D Range
14.85 15.89
52W Range
8.83 16.99
Valuation (TTM)
PE -10.98
PB 4.84
EV/EBITDA -14.05
Valuation (NTM)
Forward PE N/A
Forward PEG 0.31
Price Target $18.50
Cash Flow
FCF Yield -8.4%
SBC Adj. FCF Yield -9.7%
SBC Impact -15.8%
Margins
Gross Margin 76.6%
Operating Margin -61.1%
FCF Margin -54.0%
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y N/A |
N/A
FCF 3Y | 5Y N/A |
N/A
Returns
ROA -30.8%
ROE -38.1%
ROIC -36.3%
Financial Health
Net Cash
$73.84M
Current Ratio 8.84
Interest Coverage -28.98
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technolo...
Sector Healthcare
Employees 127
IPO Date Jul 23, 2025
Website www.carlsmed.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$18.50
Upside
+23.91%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CARL